Aktieanalys

BioInvent: Comment on BI-1206 in Solid Tumours and BI-1808 in TCL - Redeye

{newsItem.title}

Redeye Publicerad: 12 Jun 10:54

Redeye provides a comment on this week’s news flow, with new data on BI-1206 in solid tumours and BI-1808 in T-cell lymphoma.

Länk till analysen i sin helhet: https://www.redeye.se/research/1115347/bioinvent-comment-on-bi-1206-in-solid-tumours-and-bi-1808-in-tcl?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt